CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net income	$ 4,090	$ 6,717	$ 6,552
Noncash adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, amortization and other	5,592	4,071	3,417
Stock-based compensation expense	530	431	401
Deferred income taxes	(1,228)	(1,273)	(1,198)
Adjustments for equity method investments	(10)	11	891
Loss on divestiture	0	0	567
Losses (gains) on equity securities	159	(1,565)	127
Other items, net	(8)	563	(303)
Changes in operating assets and liabilities, net of acquisitions:
Trade receivables, net	441	(1,015)	(746)
Inventories	2,532	491	(742)
Other assets	(652)	(564)	258
Accounts payable	312	(402)	154
Accrued income taxes, net	(1,011)	(1,031)	(647)
Long-term tax liabilities	(492)	371	229
Accrued liabilities	92	953	97
Accrued sales incentives and allowance	1,194	935	846
Other liabilities	(51)	(222)	(182)
Net cash provided by operating activities	11,490	8,471	9,721
Cash flows from investing activities:
Cash paid for acquisitions, net of cash acquired	0	(26,989)	(3,839)
Purchases of marketable securities	0	(1)	(2,587)
Proceeds from sales of marketable securities	0	1,123	98
Proceeds from maturities of marketable securities	0	550	1,120
Purchases of property, plant and equipment	(1,096)	(1,112)	(936)
Other	50	225	100
Net cash used in investing activities	(1,046)	(26,204)	(6,044)
Cash flows from financing activities:
Net proceeds from issuance of debt	0	27,777	6,919
Extinguishment of debt	(659)	(647)	(297)
Repayment of debt	(3,600)	(1,454)	0
Repurchases of common stock	(200)	0	(6,360)
Dividends paid	(4,832)	(4,556)	(4,196)
Other	(124)	(72)	(103)
Net cash (used in) provided by financing activities	(9,415)	21,048	(4,037)
Increase (decrease) in cash and cash equivalents	1,029	3,315	(360)
Cash and cash equivalents at beginning of year	10,944	7,629	7,989
Cash and cash equivalents at end of year	$ 11,973	$ 10,944	$ 7,629